Volume 104; Issue 4
Randomized clinical trial
Randomized clinical trial comparing standard diet with perioperative oral immunonutrition in total gastrectomy for gastric cancer. BJS 2017; 104: n/a-n/a.
Authors: S. Ida, N. Hiki, H. Cho, K. Sakamaki, S. Ito, K. Fujitani et al.
Notes: Immunonutrition of no benefit
Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine‐based chemotherapy. BJS 2017; 104: 328-336.
Authors: N. T. E. Bird, M. Elmasry, R. Jones, E. Psarelli, J. Dodd, H. Malik et al.
Notes: Standardization needed to see if it's really useful
Meta‐analysis of the influence of surgical margin and adjuvant radiotherapy on local recurrence after resection of sporadic desmoid‐type fibromatosis. BJS 2017; 104: 347-357.
Authors: M. L. Janssen, D. L. M. van Broekhoven, J. M. M. Cates, W. M. Bramer, J. J. Nuyttens, A. Gronchi et al.
Notes: Radiotherapy after surgery for recurrence only
European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma. BJS 2017; 104: 358-376.
Authors: S. Gaujoux, R. Mihai, B. Carnaille, B. Dousset, C. Fiori, F. Porpiglia et al.
Notes: The best evidence available
Gastrointestinal symptoms and food intolerance 2 years after laparoscopic Roux‐en‐Y gastric bypass for morbid obesity. BJS 2017; 104: 393-400.
Authors: T. C. C. Boerlage, A. W. J. M. van de Laar, S. Westerlaken, V. E. A. Gerdes, D. P. M. Brandjes
Notes: High prevalence of food intolerance
Systemic inflammatory markers and outcome in patients with locally advanced adenocarcinoma of the oesophagus and gastro‐oesophageal junction. BJS 2017; 104: 401-407.
Authors: V. P. Jagadesham, S. M. Lagarde, A. Immanuel, S. M. Griffin
Notes: Could help in treatment stratification